Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate
- 1 July 1990
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (7), 1037-1041
- https://doi.org/10.1002/art.1780330717
Abstract
A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of methotrexate (MTX). Her serum transaminase and albumin levels were normal. A liver biopsy revealed chronic hepatitis with bridging fibrosis and piecemeal necrosis. Upon discontinuation of MTX, her ascites resolved, and her arthritis became more active. This is the third report of reversible hepatic decompensation associated with prolonged MTX therapy in patients with rheumatoid arthritis.This publication has 15 references indexed in Scilit:
- Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findingsArthritis & Rheumatism, 1989
- Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A Prospective Study with Baseline and Sequential Biopsy SamplesArthritis & Rheumatism, 1989
- Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritisThe American Journal of Medicine, 1988
- Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritisArthritis & Rheumatism, 1988
- Hepatotoxicity After Long-Term Methotrexate TherapySouthern Medical Journal, 1986
- Complications in Methotrexate Treatment of Psoriasis with Particular Reference to Liver FibrosisJournal of Investigative Dermatology, 1982
- Drug-Induced Liver Disease: An OverviewSeminars in Liver Disease, 1981
- Jaundice associated with naproxenPublished by Oxford University Press (OUP) ,1980
- Methotrexate induced liver cirrhosisBritish Journal of Dermatology, 1980
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951